1245216-92-5

Basic information

• Product Name: ethyl 2-methyl-4-[4-(methylsulfonyl)-2-(trifluoromethyl)phenoxy]-2H-indazole-6-carboxylate
• Synonyms: ethyl 2-methyl-4-[4-(methylsulfonyl)-2-(trifluoromethyl)phenoxy]-2H-indazole-6-carboxylate
• CAS NO: 1245216-92-5
• Molecular Weight: 442.416
• Mol File: 1245216-92-5.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: ethyl 2-methyl-4-[4-(methylsulfonyl)-2-(trifluoromethyl)phenoxy]-2H-indazole-6-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 2-methyl-4-[4-(methylsulfonyl)-2-(trifluoromethyl)phenoxy]-2H-indazole-6-carboxylate(1245216-92-5)
• EPA Substance Registry System: ethyl 2-methyl-4-[4-(methylsulfonyl)-2-(trifluoromethyl)phenoxy]-2H-indazole-6-carboxylate(1245216-92-5)

Safety Data

• Hazardous Substances Data: 1245216-92-5(Hazardous Substances Data)

Upstream product

• 1245215-57-9 ethyl 4-hydroxy-2-methyl-2H-indazole-6-carboxylate 
• 4163-81-9 2-chloro-5-methansulfonylbenzotrifluoride 

Relevant articles and documents

SUBSTITUTED INDAZOLE AMIDES AND THEIR USE AS GLUCOKINASE ACTIVATORS

The present invention provides a compound of Formula (I) or a pharmaceutically acceptable salt thereof wherein R1, R4, R6, X, Y and Z are as defined herein. The compounds of Formula (I) have been found to act as glucokinase activators. Consequently, the compounds of Formula (I) and the pharmaceutical compositions thereof are useful for the treatment of diseases, disorders, or conditions mediated by glucokinase.